Leukotriene receptor antagonist vs placebo
Clinical improvement (dichotomous) · inactive EoE patients
It is very uncertain whether leukotriene receptor antagonist changes clinical improvement at 26 weeks (dichotomous) compared with placebo (very low certainty).
1 finding from 1 review
- RR 1.68 [0.66, 4.28]1 study · 41 participantsVery low